Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived mesenchymal stem cells for Alzheimer's disease
jRCTb030190214Completed
- Sponsor
- JASC
- Start
- Jun 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in Alzheimer's disease (AD), sponsored by JASC. Primary endpoints: Frequency of adverse events and ADAS-Jcog. Started Jun 2019; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCTb030190214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb030190214.